13/08168 - Realtor agent services associated entering into leasing agreements

Statens Legemiddelverk

The objective of the acquisition is to enter into an agreement for the purchase of technical and mercantile consultancy and project management services, including marketing and negotiation expertise related to the specification of needs, requirement specifications and the negotiations of new lease agreements for The Norwegian Medicines Agency, hereafter referred to as the Awarding Authority. The Awarding Authority currently has their offices located at Sven Oftedalsvei 6-8 in Oslo. The current lease agreement expires on the 31.12.2016. In connection with this, there shall be established a new lease agreement for approx. 250 employees for the Awarding Authority, with primarily ordinary office facilities as well as laboratories and animal research facilities.
A further detailed description of the acquisition is provided in the specification requirements in Section 6.2.
NOTE: To register your interest in this notice and obtain any additional information please visit the Doffin Web Site at http://www.doffin.no/Search/Search_Switch.aspx?ID=295926

Frist

Fristen for mottak av tilbud var 2013-08-13. Anskaffelsen ble publisert 2013-06-03.

Hvem? Hva? Hvor?
Anskaffelseshistorikk
Dato Dokument
2013-06-03 Kunngjøring av konkurranse
Kunngjøring av konkurranse (2013-06-03)
Gjenstand
Anskaffelsens omfang
Tittel: Commercial property management services
Antall eller omfang:
The financial framework is estimated up to 2 million Norwegian krone spread over the contract period.
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Tjenester
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Forvaltning av næringseiendommer 📦

Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet

Oppdragsgiver
Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Nasjonalt eller føderalt byrå/kontor
Navn på tildelende myndighet: Statens legemiddelverk
Postadresse: Sven Oftedals Vei 8,
Postnummer: 0950
Poststed: Oslo
Kontakt
Internettadresse: http://www.legemiddelverket.no 🌏
Telefon: +47 22897700 📞
Faks: +47 22897799 📠

Referanse
Datoer
Sendt dato: 2013-06-03 📅
Innleveringsfrist: 2013-08-13 📅
Publiseringsdato: 2013-06-05 📅
Identifikatorer
Kunngjøringsnummer: 2013/S 107-183866
OJ-S-utgave: 107
Tilleggsinformasjon
(NT Ref:296114)

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The objective of the acquisition is to enter into an agreement for the purchase of technical and mercantile consultancy and project management services, including marketing and negotiation expertise related to the specification of needs, requirement specifications and the negotiations of new lease agreements for The Norwegian Medicines Agency, hereafter referred to as the Awarding Authority. The Awarding Authority currently has their offices located at Sven Oftedalsvei 6-8 in Oslo. The current lease agreement expires on the 31.12.2016. In connection with this, there shall be established a new lease agreement for approx. 250 employees for the Awarding Authority, with primarily ordinary office facilities as well as laboratories and animal research facilities.
Vis mer
A further detailed description of the acquisition is provided in the specification requirements in Section 6.2.
NOTE: To register your interest in this notice and obtain any additional information please visit the Doffin Web Site at http://www.doffin.no/Search/Search_Switch.aspx?ID=295926
Utførelsessted
Hovedsted eller utførelsessted: Oslo, Norway.

Juridisk, økonomisk, finansiell og teknisk informasjon
Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten:
(1) Company registration certificate.
(2) Value added tax certificate (National requirement).
(3) Company tax certificate (National requirement).
(4) Self-declaration in compliance with Appendix 2 (HSE) of the Norwegian procurement regulations (National requirement).
Økonomisk og finansiell stilling:
(1) The company's most recent annual report including new information of relevance to the company's accounting figures.
(2) Presentation of the company's annual accounts, or extracts thereof.
(3) Other documentation required (please state below).
Refer to section 7.2 in the tender documents.
Minste nivå(er) av standarder: Refer to section 7.3 in the tender documents.
Teknisk og faglig kapasitet:
(1) Overview of the company's total manpower.
(2) Manpower proposed for this contract (organisation chart) with names and CV's of the key personnel who will be responsible for its execution (for service and works contracts).
(3) A list of the principal deliveries effected, or main services provided, by the company, in the past three years, with the values, dates and recipients (for supply and service contracts).
Kontraktutførelse
Hovedfinansieringsvilkår og betalingsordninger og/eller henvisning til relevante bestemmelser som regulerer dem: Refer to the tender documents.

Prosedyre
Tilbudets gyldighetsperiode: 2013-09-30 📅
Dato for åpning av tilbud: 2013-08-13 📅
Åpningssted: Statens legemiddelverk, Norway.
Sted: Statens legemiddelverk, Norway.
Språk
Andre språk: Norwegian

Oppdragsgiver
Kontakt
Kontaktpunkt: Administrasjonsavdelingen
Liv Sigurdsson
Adresse til kjøperprofilen: http://www.doffin.no//search/Search_AuthProfile.aspx?ID=AA0273 🌏
Navn: Statens legemiddelverk
Postadresse: Sven Oftedals Vei 8
E-post: liv.sigurdsson@legemiddelverket.no 📧
URL for ytterligere informasjon: http://www.legemiddelverket.no 🌏
URL for dokumenter: http://www.legemiddelverket.no 🌏
URL for deltakelse: http://www.legemiddelverket.no 🌏

Utfyllende informasjon
Klageinstans
Navn: Statens legemiddelverk
Postadresse: Postboks 63, Kalbakken
Poststed: Oslo
Postnummer: 0901
Land: Norge 🇳🇴
E-post: liv.sigurdsson@legemiddelverket.no 📧
Telefon: +47 41600820 📞
Informasjon om frister for klage: 16.9.2013.
Tjeneste hvor informasjon om klageprosedyren kan innhentes
Samme som: Klageinstans
Kilde: OJS 2013/S 107-183866 (2013-06-03)